✦ LIBER ✦

Vascular Targeting and Therapeutics for Squamous Cell Carcinoma of the Head and Neck

✍ Scribed by Nabil F. Saba, Zhuo (Georgia) Chen, Professor Dong M. Shin

Book ID: 120840586
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2006
Tongue: English
Weight: 218 KB
Volume: 5
Category: Article
ISSN: 0099-7374
DOI: 10.2165/00024669-200605010-00002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Novel therapeutic targets in squamous ce

Novel therapeutic targets in squamous cell carcinoma of the head and neck

✍ Ezra E.W. Cohen 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 348 KB

p53-based therapeutics for head and neck

p53-based therapeutics for head and neck squamous cell carcinoma

✍ Tassone, Patrick; Old, Matthew; Teknos, Theodoros N.; Pan, Quintin 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 348 KB

MicroRNA-138: A potential therapeutic ta

MicroRNA-138: A potential therapeutic target for head and neck squamous cell carcinoma (HNSCC)

✍ Xu, Ji-Liang; Xia, Rong 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 187 KB

Therapeutic targets in head and neck squ

Therapeutic targets in head and neck squamous cell carcinoma: Identification, evaluation, and clinical translation

✍ Jason D. Howard; Bo Lu; Christine H. Chung 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 454 KB

Genetically targeted radiotherapy of hea

Genetically targeted radiotherapy of head and neck squamous cell carcinoma

✍ Andrew W. Gaut; Kimberly Krager; Frederick E. Domann 📂 Article 📅 2004 🏛 SAGE Publications 🌐 English ⚖ 36 KB

Targeted therapies in squamous cell carc

Targeted therapies in squamous cell carcinoma of the head and neck

✍ Kathryn A. Gold; Ho-Young Lee; Edward S. Kim 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 3 views

## Abstract Head and neck cancer is a challenging disease that is expected to account for greater than 500,000 new cases worldwide in 2008. Toxicity has impeded advances in chemotherapy and radiation for head and neck cancer, and the prognosis for patients with recurrent and/or metastatic disease r